Literature DB >> 20308607

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.

Deidra C Crews1, Laura C Plantinga, Edgar R Miller, Rajiv Saran, Elizabeth Hedgeman, Sharon H Saydah, Desmond E Williams, Neil R Powe.   

Abstract

Hypertension is both a cause and a consequence of chronic kidney disease, but the prevalence of chronic kidney disease throughout the diagnostic spectrum of blood pressure has not been established. We determined the prevalence of chronic kidney disease within blood pressure categories in 17 794 adults surveyed by the National Health and Nutrition Examination Survey during 1999-2006. Diagnosed hypertension was defined as self-reported provider diagnosis (n=5832); undiagnosed hypertension was defined as systolic blood pressure > or = 140 mm Hg or diastolic blood pressure > or = 90 mm Hg, without report of provider diagnosis (n=3046); prehypertension was defined as systolic blood pressure > or = 120 and <140 mm Hg or diastolic blood pressure > or = 80 and <90 mm Hg (n=3719); and normal was defined as systolic blood pressure <120 mm Hg and diastolic blood pressure <80 mm Hg (n=5197). Chronic kidney disease was defined as estimated glomerular filtration rate <60 mL/min per 1.73 m(2) or urinary albumin:creatinine ratio >30 mg/g. Prevalences of chronic kidney disease among those with prehypertension and undiagnosed hypertension were 17.3% and 22.0%, respectively, compared with 27.5% with diagnosed hypertension and 13.4% with normal blood pressure, after adjustment for age, sex, and race in multivariable logistic regression. This pattern persisted with varying definitions of kidney disease; macroalbuminuria (urinary albumin:creatinine ratio >300 mg/g) had the strongest association with increasing blood pressure category (odds ratio: 2.37 [95% CI: 2.00 to 2.81]). Chronic kidney disease is prevalent in undiagnosed and prehypertension. Earlier identification and treatment of both these conditions may prevent or delay morbidity and mortality from chronic kidney disease.

Entities:  

Mesh:

Year:  2010        PMID: 20308607      PMCID: PMC2880533          DOI: 10.1161/HYPERTENSIONAHA.110.150722

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures.

Authors: 
Journal:  Vital Health Stat 1       Date:  1994-07

3.  Blood pressure predicts risk of developing end-stage renal disease in men and women.

Authors:  Masahiko Tozawa; Kunitoshi Iseki; Chiho Iseki; Kozen Kinjo; Yoshiharu Ikemiya; Shuichi Takishita
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

4.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

5.  Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

Authors:  Josef Coresh; Danita Byrd-Holt; Brad C Astor; Josephine P Briggs; Paul W Eggers; David A Lacher; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

6.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Jeanne Darbinian; Alan S Go; Carlos Iribarren
Journal:  Arch Intern Med       Date:  2005-04-25

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Screening for proteinuria in US adults: a cost-effectiveness analysis.

Authors:  L Ebony Boulware; Bernard G Jaar; Michelle E Tarver-Carr; Frederick L Brancati; Neil R Powe
Journal:  JAMA       Date:  2003-12-17       Impact factor: 56.272

9.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

View more
  51 in total

1.  Editorial commentary.

Authors:  Michael J Meagher; Tonya Lowery St John
Journal:  Hawaii J Med Public Health       Date:  2012-07

2.  Epidemiology of chronic kidney disease among normotensives: but what is chronic kidney disease?

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-03-22       Impact factor: 10.190

Review 3.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

4.  Trends in estimated kidney function: the FINRISK surveys.

Authors:  Auni Juutilainen; Helena Kastarinen; Riitta Antikainen; Markku Peltonen; Veikko Salomaa; Jaakko Tuomilehto; Pekka Jousilahti; Jouko Sundvall; Tiina Laatikainen; Mika Kastarinen
Journal:  Eur J Epidemiol       Date:  2012-04       Impact factor: 8.082

5.  Prehypertension-new insights for health risks.

Authors:  Tianyu Xu; Yuli Huang
Journal:  Nat Rev Cardiol       Date:  2015-05-19       Impact factor: 32.419

6.  Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample.

Authors:  Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Michael Shanahan; Kathleen Mullan Harris; Glen H Elder; Redford B Williams
Journal:  Hypertension       Date:  2011-07-05       Impact factor: 10.190

7.  Relationship between prehypertension and incidence of chronic kidney disease in a general population: a prospective analysis in central south China.

Authors:  Xia Cao; Xiumei Xie; Jiansong Zhou; Hong Yuan; Zhiheng Chen
Journal:  Int Urol Nephrol       Date:  2014-08-19       Impact factor: 2.370

8.  Association between undiagnosed hypertension and microalbuminuria in South Asians without known diabetes.

Authors:  R W Major; M J Davies; W Crasto; L J Gray; D R Webb; K Khunti
Journal:  J Hum Hypertens       Date:  2014-08-14       Impact factor: 3.012

9.  The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.

Authors:  Jorge H Capdevila; Nataliya Pidkovka; Shaojun Mei; Yan Gong; John R Falck; John D Imig; Raymond C Harris; Wenhui Wang
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

10.  Food Access, Chronic Kidney Disease, and Hypertension in the U.S.

Authors:  Jonathan J Suarez; Tamara Isakova; Cheryl A M Anderson; L Ebony Boulware; Myles Wolf; Julia J Scialla
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.